1BOA | pdb_00001boa

HUMAN METHIONINE AMINOPEPTIDASE 2 COMPLEXED WITH ANGIOGENESIS INHIBITOR FUMAGILLIN

• PDB DOI: https://doi.org/10.2210/pdb1BOA/pdb

• Classification: AMINOPEPTIDASE
• Organism(s): Homo sapiens
• Expression System: Spodoptera frugiperda
• Mutation(s): No 


• Deposited: 1998-08-01 Released: 1999-08-01 
• Deposition Author(s): Liu, S., Widom, J., Kemp, C.W., Crews, C.M., Clardy, J.C.

---

Experimental Data Snapshot

• Method: X-RAY DIFFRACTION
• Resolution: 1.80 Å
• R-Value Free: 
  0.232 (Depositor) 
• R-Value Work: 
  0.193 (Depositor) 

Starting Model: experimental

Literature

Structure of human methionine aminopeptidase-2 complexed with fumagillin.

Liu, S., Widom, J., Kemp, C.W., Crews, C.M., Clardy, J.

(1998) Science 282: 1324-1327

• PubMed: 9812898 
• DOI: https://doi.org/10.1126/science.282.5392.1324
• Primary Citation Related Structures: 
  1B59, 1B6A, 1BN5, 1BOA


• PubMed Abstract: 
  

  The fungal metabolite fumagillin suppresses the formation of new blood vessels, and a fumagillin analog is currently in clinical trials as an anticancer agent. The molecular target of fumagillin is methionine aminopeptidase-2 (MetAP-2). A 1.8 A resolution crystal structure of free and inhibited human MetAP-2 shows a covalent bond formed between a reactive epoxide of fumagillin and histidine-231 in the active site of MetAP-2. Extensive hydrophobic and water-mediated polar interactions with other parts of fumagillin provide additional affinity. Fumagillin-based drugs inhibit MetAP-2 but not MetAP-1, and the three-dimensional structure also indicates the likely determinants of this specificity. The structural basis for fumagillin's potency and specificity forms the starting point for structure-based drug design.

---

Organizational Affiliation: 
• J. Clardy, Department of Chemistry and Chemical Biology, Baker Laboratory, Cornell University, Ithaca, NY 14853-1301, USA.

Biological Assembly 1  

Global Symmetry: Asymmetric - C1 
Global Stoichiometry: Monomer - A1 

Biological assembly 1 assigned by authors.

Macromolecule Content 

• Total Structure Weight: 53.56 kDa 
• Atom Count: 3,008 
• Modeled Residue Count: 354 
• Deposited Residue Count: 478 
• Unique protein chains: 1

Macromolecules

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details	Image
METHIONINE AMINOPEPTIDASE	A	478	Homo sapiens	Mutation(s): 0  EC: 3.4.11.18
UniProt & NIH Common Fund Data Resources
Find proteins for P50579 (Homo sapiens) Explore P50579  Go to UniProtKB:  P50579
PHAROS:  P50579 GTEx:  ENSG00000111142

Small Molecules

Ligands 2 Unique
ID	Chains	Name / Formula / InChI Key	2D Diagram
FUG	D [auth A]	FUMAGILLIN C26 H36 O7 XXVWUXWNPOXVQB-ZFSLZHKLSA-N
CO	B [auth A], C [auth A]	COBALT (II) ION Co XLJKHNWPARRRJB-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

• Method: X-RAY DIFFRACTION
• Resolution: 1.80 Å
• R-Value Free:  0.232 (Depositor) 
• R-Value Work:  0.193 (Depositor) 

Space Group: C 2 2 2₁

Unit Cell:

Length ( Å )	Angle ( ˚ )
a = 90.7	α = 90
b = 99.58	β = 90
c = 101.95	γ = 90

Software Package:

Software Name	Purpose
MOSFLM	data reduction
SCALA	data scaling
AMoRE	phasing
REFMAC	refinement
CCP4	data scaling

Structure Validation

Entry History 

Deposition Data

• Released Date: 1999-08-01 
Deposition Author(s): Liu, S., Widom, J., Kemp, C.W., Crews, C.M., Clardy, J.C.

Revision History  

• Version 1.0: 1999-08-01
  Type: Initial release
  
• Version 1.1: 2008-03-24
  Changes: Version format compliance
• Version 1.2: 2011-07-13
  Changes: Version format compliance
• Version 1.3: 2023-08-09
  Changes: Database references, Derived calculations, Refinement description
• Version 1.4: 2024-10-16
  Changes: Data collection, Structure summary